Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

K!N4E4 > K!N4E4 Midterm 2 > Flashcards

K!N4E4 Midterm 2 Flashcards

1
Q

What are the goals of pretreatment (prehabilitation)?

A

reduce side effects/complications, hasten recovery, qualify for treatment, delay/prevent treatment (treat disease), improve treatment efficacy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the goals of treatment (tolerance/efficacy)?

A

prevent/manage side effects and complications, complete treatment, treat disease, make treatment more effective, and hasten recovery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the duration of
RT?
CT?
HT?
IT?

A

RT=5-6 weeks
CT=4-6 months
HT=years
IT=years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the goals of survivorship (rehab/recovery)(prevention/promotion)?

A

recover from acute side effects (including deconditioning), prevent/manage long term side effects, lower disease risk (including recurrence), improve survival and general health promotion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the goals of end of life (palliation)?

A

symptom management (pain, constipation, poor appetite, psychosocial distress), maintain functional independence, improve quality of life, slow disease progression, and improve survival

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How many cancer patients die from disease?

A

50%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are 8 disease variables?

A

Type of Cancer
Subtype of Cancer
Disease Stage
Tumor Grade
Tumor Biomarkers
Time since diagnosis
Treatment Response
Disease Outcomes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is type of cancer?

A

Major Cancer sites such as breast, lung, colorectal, lymphoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is subtype of cancer?

A

Lymphoma subtypes include diffuse large B cell, follicular, and mantle cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is disease stage?

A

Extent and spread of the cancer, usually ranging from stage 1 to stage 4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is tumor grade?

A

Indicator of the abnormality and aggressiveness of the cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is tumor biomarkers?

A

Estrogen receptor status, progesterone receptor status, HER2 status

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is time since diagnosis?

A

Common cut points are 2, 5 and 10 years.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is treatment response?

A

Disease can progress, stabilize, or show a partial or complete response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is disease outcomes?

A

Recurrence-free survival, progression-free survival, second primary cancers, deaths from treatment toxicity, cancer-specific survival, and overall survival

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the 8 treatment variables?

A

Surgery
Radiation Therapy
Chemotherapy
Endocrine Therapy (hormone therapy)
Biologic therapy (immunotherapy)
Stem cell transplant (bone marrow transplant)
Multimodal therapy
Average relative dose intensity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is surgery as a treatment variable?

A

type, location, and extent (partial vs radical nephrectomy)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is radiation therapy as a treatment variable?

A

ionizing radiation of varying types, field locations, dosing, and schedules

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is chemotherapy as a treatment variable?

A

cytotoxic drugs of various types, administration, and scheduling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is endocrine therapy (hormone therapy) as a treatment variable?

A

Hormone treatments (aromatase inhibitors)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What is biologic therapy (immunotherapy)?

A

uses the body’s immune system to fight cancer (herceptin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What is stem cell transplant (bone marrow) as a treatment variable?

A

used to restore the stem cells when the bone marrow has been destroyed by disease, chemo, or radiation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What is multimodal therapy as a treatment variable?

A

combination and sequencing of different treatments

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What is average relative dose intensity?

A

percentage of the planned chemotherapy dose received

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What are the four propositions of the field of physical activity and cancer survivorship.

A

1: Cancer variables may be outcomes of PA
2: Cancer variables may be moderators of PA outcomes
3: Cancer variables may be determinants of PA
4: Cancer variables may be moderators of PA determinants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What does cancer variables may be outcomes of PA mean?

A
  • PA may influence treatment decisions, completion rates, and efficacy (response)
  • PA may influence disease transformations, progression, recurrence, and survival
  • Cancer outcomes of PA may be intermediate outcomes for other outcomes
  • fear of cancer recurrence is a major issue
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

What are the 4 cancer outcomes by phase?

A

 pretreatment: progression, treatment eligibility, completion, and efficacy/response
 treatment: completion, efficacy/response
 survivorship: recurrence, survival
 palliative: progression, survival

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

What does Cancer Variables may be moderators of PA Outcomes mean??

A

 may alter typical observed exercise response
 health-related fitness, psychosocial outcomes, QoL outcomes, cancer outcomes, and mechanisms
 may negate or amplify “standard” effects.
 any CV may moderate any exercise outcome
 may also influence what PA motives are promoted

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

What does Cancer variables may be determinants of PA mean?

A
  • may influence adherence and participation
  • CV’s may impact any aspect of PA (type, volume, intensity, progression, pattern, context).
  • may influence any social cognitive mediators of PA (attitude, control, support, intention)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

What does Cancer variables may be moderators of PA determinants mean?

A
  • demographic, medical, environmental, social cognitive
  • any CV may moderate any PA correlate
  • may influence which determinants are targeted.
  • may alter effectiveness of PA behavior change interventions (who, what, when, where)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

What is the basic proposition of EX oncology?

A

if cancer variables are not outcomes of PA, if they do not moderate other outcomes of PA, if they are not determinants of PA, or if they do not moderate other determinants of PA, then the case for the field of EX oncology is weak (we would apply exercise research from other populations without concern for CV)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

What is “PICOS” for Exercise Oncology?

A

 Population: disease and treatment variables
 Intervention: any exercise prescription
 Comparison: standard of care in cancer
 Outcome: relevant to cancer patients
 Study designs: RCTs where feasible

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

What are the 3 current settings for rehabilitations?

A
  • pending treatments (time from decision until treatment) time is usually fairly short
  • possible treatments (not “fit” for treatment) not very common (lung/major surgery)
  • active surveillance (decision is not to treat right away) prostate/breast
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

What are the specific goals of pre-treatment?

A

 reduce side effects/complications
 hasten recovery after treatment
 make treatment more effective
 qualify for treatment (if “unfit” for treatment)
 delay/prevent treatment (treat disease) if patient is on active surveillance

35
Q

What has good evidence from the overall results for pre-treatment?

A

 feasibility in some settings
 ↑ physical fitness and physical functioning
 ↑ some psychosocial outcomes and QoL

36
Q

What has limited evidence form the overall results for pre-treatment?

A

 surgical complications
 length of hospital stay
 time to adjuvant therapy
 treatment/disease outcomes (preclinical/animal studies)

37
Q

What are 3 key mecanisms in direct exercise effects on cancer?

A
  • cell growth regulators
  • immune system components
  • inflammation
38
Q

What are the 3 major findings from “High Shear Stresses under Exercise Condition Destroy Circulating Tumor Cells in a Microfluidic System?

A
  1. High shear stress of 60 dynes/cm2 achievable during intensive exercise killed more CTCs than low shear stress of 15 dynes/cm2 present in human arteries
  2. High shear stress caused necrosis in over 90% of CTCs within the first 4h circulation. The CTCs that survived the first 4h underwent apoptosis 16-24h post-circulation incubation
  3. Prolonged high shear stress reduced viability of highly metastatic and drug resistant breast cancer cells. Intensive exercise may be good strategy for generating high shear stress to destroy CTCs and prevent metastasis
39
Q

What does EX during cancer treatment improve/manage?

A

 physical fitness and physical functioning
 body composition (muscle loss, fat gain)
 some symptoms (fatigue, pain, sleep, depression)
 some aspects of QoL (physical and functional)

40
Q

For the results for EX during treatment what is there preliminary evidence for?

A

Improved:
 chemotherapy completion rate,
 treatment response and cancer outcomes

41
Q

What are 5 mechanisms of improved treatment efficacy?

A

 ↑ angiogenesis and intratumoral vascularization
 ↑ intratumoral blood perfusion
 ↓ intratumoral hypoxia
 ↑ intratumoral immune cell infiltration
 ↑ delivery of other blood elements/products

42
Q

What were the results of the “Fluidic shear stress increases the anti-cancer effects of ROS-generating drugs in circulating tumor cells” study?

A

Fluidic SS significantly increased the potency of the ROS-generating drugs doxorubicin (DOX) and cisplatin but had little effect on the non-ROS-generating drugs Taxol and etoposide
- basically shear stress makes some drugs more effective

43
Q

What does the HELP trial stand for?

A

Healthy Exercise for Lymphoma Patients

44
Q

What was the HELP trial?

A

 RCT comparing AET to UC in 122 lymphoma patients receiving chemotherapy or off treatments
 12 weeks supervised exercise training
 primary endpoint TOI-An
 secondary endpoints of HRF, PROs, medical

45
Q

What is a key takeaway from the HELP trial?

A

A healthy dose of exercise is good medicine, even for lymphoma patients receiving chemotherapy

46
Q

What was the EXERT trial?

A

Exercise during and after neoadjuvant rectal cancer treatment

47
Q

What was the major finding of the EXERT trial?

A

Patients with rectal cancer who exercise while recieving radiation therapy more likely to have tumors disappear

47
Q

What was the START trial?

A

Supervised Trial of Aerobic versus Resistance Training
 RCT examining AET versus RET versus UC in 242 BC patients on chemotherapy.

47
Q

What are the 5 steps of Rectal Cancer Treatment with timelines?

A

Chemoradiation (5-6weeks)
Break (6-8 weeks)
Surgery
Break (4-12weeks)
Chemo (4-4.5 months)

48
Q

For the START trial? Did taxane or non-taxane have great resistance training response?

A

Non-taxane has better increase in strength

49
Q

How does the stage of disease effect muscle mass changes in START trial?

A

Later stages of disease has larger improvements in muscle mass changes (both RT atnd AT)

50
Q

What effects did the START trial have on relative dose intensity? (RDI)

A

resistance training had a statistically significant relative dose intensity compared to the control group (~90% completion)

51
Q

What are the 5 steps of the recommended process for targeted exercise prescription for cancer patients?

A
  1. patient assessment
  2. determine health issues
  3. identify patient capacity and intervention suitability
  4. exercise prescription
  5. reassessment and modification
52
Q

What are considerations for patients with anemia?

A
  • shorter duration aerobic
  • lower intensity
53
Q

What are considerations for patients with thrombocytopenia?

A
  • avoid exercise with a risk of falls or blunt forces
  • water based activity is good
54
Q

What are considerations for patients with neutropenia?

A
  • avoid high intensity
  • encourage hand washing
  • avoid crowded locations
55
Q

What are considerations for patients with sarcopenia?

A
  • increased resistance training to maintain muscle mass
56
Q

What are the goals of posttreatment?

A

recover from acute side effects (including deconditioning), prevent/manage long term side effects and complications, general health promotion, treat disease (progression/recurrence)

57
Q

What does exercise after treatment improve/manage?

A

 similar outcomes during treatment but stronger effects,
 larger and more rapid improvements in fitness and QoL,
 some biomarkers related to cancer/disease

58
Q

What is precision medicine?

A

 attempt to address substantial heterogeneity in patient disease and response to therapy
 “tailoring of medical treatments to the individual characteristics of each patient”
 “medical care to optimize therapeutic benefit for particular groups of patients, using genetic or molecular profiling” (subgroups)

59
Q

What is the primary goal of precision medicine?

A

give an intervention to patients who will benefit and not give it to patients who will not benefit (or be harmed)

59
Q

What is the secondary goal of precision medicine?

A

avoid the side effects and costs of giving the intervention to patients who will not benefit (or will be harmed)

60
Q

What is the main difference between public health and precision medicine?

A

public health focuses on the population level
precision medicine focuses on an individual level

61
Q

Why is precision medicine and exercise needed?

A

substantial variability in response to exercise interventions

62
Q

What is precision medicine trying to understand?

A

not about understanding biological factors that are mechanisms (mediators) but biological factors that predict response (moderators)

63
Q

What are you trying to identify with precision medicine?

A

genetic or molecular subgroups of patients whose cancer outcomes are benefitted (or harmed) by specific exercise prescriptions
- if subgroups could be identified, likely patients would be highly motivated to perform the targeted exercise prescription

64
Q

What are the exercise recommendation highlights from the American Society of Clinical Oncology?

A

Oncology providers should recommend aerobic and resistance exercise during active treatment with curative intent to mitigate side effects of cancer treatment.
-reduce fatigue
-preserve cardiorespiratory fitness and strength
-improve QoL
-reduce anxiety and depression
-have low risk of adverse events

65
Q

What are the 5 cancer specific exercise factors?

A

 type and subtype of cancer
 stage of disease
 phase of the cancer continuum/trajectory
 type of treatments
 nature and severity of side effects

66
Q

What are the 5 general exercise principles?

A

 avoid inactivity; sedentary behavior is bad
 some exercise is better than none.
 more exercise is better (dose-response).
 start easy and progress slowly.
 exercise must be individualized based on patient function, side effects, preferences, and goals

67
Q

For exercise in cancer patients, what is the most compelling efficacy outcome?

A

 cancer outcomes (if supported by evidence)
 cancer-specific symptoms/side effects
 general health-related fitness outcomes

68
Q

For exercise in cancer patients, what are the most important feasibility / safety issues?

A

 surgical limitations/complications
 RT side effects
 chemotherapy/drug side effects

69
Q

What is the 2 step process for exercise prescription?

A

Step 1: Develop EX prescription based on efficacy
- cancer outcomes, symptom management
Step 2: Modify EX prescription based on safety/feasibility
- driven by symptoms/side effects/toxicities

70
Q

What are the 4 exercise prescription components?

A

 type or mode of activity
 total weekly amount or volume
 “fractionation” (frequency, intensity, duration)
 context (physical and social environment)

71
Q

What is the generic recommended exercise guidelines for patients?

A

 150 minutes/week of mod intensity aerobic EX.
 75 minutes/week of vig intensity aerobic EX.
 or equivalent combination ex. 50 mod + 50 vig).
 2-3 days/week of strength exercises of major muscle groups using 8-12 repetitions; 3 days of balance

72
Q

What is the primary dose reduction strategy?

A

intensity

73
Q

Does exercise context matter?

A
  • social context important for optimizing psychosocial health
  • EX should engage the mind and spirit, not just the body
74
Q

What are 7 Safety (risks) of EX in Cancer Patients?

A

 low exercise capacity and decreased strength
 low blood counts (myelosuppression)
 poor balance and coordination (ataxia)
 peripheral neuropathy
 increased fatigue
 decreased cognitive status
 bone metastases

75
Q

What are 5 potential adverse effects of exercise during or after treatment?

A
  • exacerbation of symptoms (pain, fatigue, nausea, dyspnea)
  • immunosuppression
  • falls
  • bone fracture
  • lymphoedema
76
Q

What are the 3 variables of survivors meeting the PA guidelines?

A
  • time since diagnosis
  • disease status
  • disease stage
77
Q

What was the only statistically significant variable between cancer/medical variables and exercise behaviour?

A

Major cancer type

78
Q

What was different about the CARE trial?

A

it was objective exercise data compared to most other ones were self-report

79
Q

What 2 variables were statistically significant in the CARE trial?

A

Length of chemo protocol:
- shorter chemo, better adherence to exercise programs
FEC-D:
REC-D is difficult to adhere to

80
Q

What 2 types of cancer are associated with Affective Attitudes?

A

Breast, Prostate
NOT colorectal

81
Q
A

K!N4E4 (3 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions